These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36710490)

  • 41. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study.
    Cheng Y; Wang Q; Li K; Shi J; Liu Y; Wu L; Han B; Chen G; He J; Wang J; Lou D; Yu H; Wang S; Qin H; Li X
    Br J Cancer; 2021 Aug; 125(3):366-371. PubMed ID: 34006926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non-small cell lung cancer: Rvision-001 study protocol.
    Wang Y; Wang X; Guan Y; Song Y; Zhuang H; Wang E
    Thorac Cancer; 2020 May; 11(5):1361-1364. PubMed ID: 32163662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial.
    Shen Y; Lu J; Hu F; Qian J; Zhang X; Zhong R; Zhong H; Chu T; Han B
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1417-1424. PubMed ID: 35482076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study Design and Rationale for a Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Selumetinib in Combination With Docetaxel as Second-Line Treatment in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer (SELECT-1).
    Jänne PA; Mann H; Ghiorghiu D
    Clin Lung Cancer; 2016 Mar; 17(2):e1-4. PubMed ID: 26837474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
    Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
    Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anlotinib hydrochloride consolidation after concurrent chemoradiotherapy in stage III non-small-cell lung cancer: a truncated, randomized, multicenter, clinical study (ALTER-L029).
    Yang D; Li X; Xue X; Jiang L; Shi A; Zhao J
    Anticancer Drugs; 2024 Aug; 35(7):680-685. PubMed ID: 38718190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
    Liu M; Di YM; Zhang L; Yang L; Zhang L; Chen J; Wang R; Xie X; Lan F; Xie L; Huang J; Zhang AL; Xue CC; Liu X
    Front Endocrinol (Lausanne); 2024; 15():1334609. PubMed ID: 38390199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial).
    Hu L; Liang G; Yuliang W; Bingjing Z; Xiangdong Z; Rufu X
    Trials; 2013 Feb; 14():45. PubMed ID: 23413951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.
    He J; Li Z; Huang W; Guan W; Ma H; Yang ZF; Wang X
    BMJ Open; 2019 Apr; 9(4):e024800. PubMed ID: 30944133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.
    Zhou C; Wu YL; Chen G; Liu X; Zhu Y; Lu S; Feng J; He J; Han B; Wang J; Jiang G; Hu C; Zhang H; Cheng G; Song X; Lu Y; Pan H; Zheng W; Yin AY
    J Clin Oncol; 2015 Jul; 33(19):2197-204. PubMed ID: 26014294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of anlotinib combined with carboplatin and pemetrexed as first-line induction therapy followed by anlotinib plus pemetrexed as maintenance therapy in
    He Z; Yang X; Ma T; Yang Q; Zhang C; Chen Y; Wang P; D'Incecco A; Metro G; Uematsu S; Wang Q
    Transl Lung Cancer Res; 2022 Aug; 11(8):1657-1666. PubMed ID: 36090635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer.
    Sun M; Zhou T; Fang X; Wang D; Pang H; Chen Y; Hu K
    Medicine (Baltimore); 2020 Aug; 99(33):e21626. PubMed ID: 32872022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials.
    Weng S; Fan Z; Qiu G; Liu F; Huang L; Li J; Jiang X; Song Z; Gao Y; Zhong Z; He L; Kang L; Wu Y; Chen B; Jiang Q
    Medicine (Baltimore); 2020 Dec; 99(51):e23679. PubMed ID: 33371107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial.
    Fu Q; Xie H; Zhou L; Li X; Liu Y; Liu M; Wang C; Wang X; Wang Z; Tang J; Xiao H; Xiao Z; Zhou J; Feng C; Wang L; Ao Z; Chen X; Su C; Wu X; Zhao M; Hu S; Lin H; Huang J; Xu G; Zhang Q; Jiang L
    Trials; 2021 Feb; 22(1):162. PubMed ID: 33632286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial.
    Xiao Z; Chen Z; Han R; Lu L; Li Z; Lin J; Hu L; Huang X; Lin L
    Medicine (Baltimore); 2021 May; 100(18):e25690. PubMed ID: 33950949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.